ADMEDUS @ADMEDUS
Welcome Jim Lemle, our new US Director of National Commercial Accounts, who brings a 25 year track record in the medical device industry
[BCOLOR=rgba(64,46,39,1.0)][/BCOLOR]
3:56 PM - 29 Mar 2017 from Minneapolis, MN
This appointment and tweet was made back at end of March. I imagine Jane Catterson and Jim Lemle work in collaboration on these deals. Great work! Jim and Jane.... Keep these deals coming!
Professor Neethling named VP of Cardiovascular Technologies, page-33
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.97 |
Change
-0.235(1.29%) |
Mkt cap ! $345.3M | |||
| Open | High | Low | Value | Volume |
| $18.09 | $18.09 | $17.88 | $1.182K | 66 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 60 | $17.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.05 | 554 | 1 |
View Market Depth
| Last trade - 14.30pm 10/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |